The TRAIL receptor agonist drozitumab targets basal B...

Breast Cancer Research and Treatment 2016 / 1 Vol. 155; Iss. 2

The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl

Dine, Jennifer L., O’Sullivan, Ciara C., Voeller, Donna, Greer, Yoshimi E., Chavez, Kathryn J., Conway, Catherine M., Sinclair, Sarah, Stone, Brandon, Amiri-Kordestani, Laleh, Merchant, Anand S., Hewi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
155
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-015-3673-z
Date:
January, 2016
File:
PDF, 1.85 MB
english, 2016
Conversion to is in progress
Conversion to is failed